Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tamás Lajtos"'
Autor:
Nirupam Purkayastha, Myles Lewis, Katriona Goldmann, W.S. Tan, Alessandra Nerviani, Stephen Kelly, Marie-Astrid Boutet, Tamás Lajtos, Costantino Pitzalis, Rebecca Hands
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesTo determine the relationship between synovial versus skin transcriptional/histological profiles in patients with active psoriatic arthritis (PsA) and explore mechanistic links between diseased tissue pathology and clinical outcomes.Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a9eb1d14d750c870bd378942d36860
https://doi.org/10.1136/annrheumdis-2020-218186
https://doi.org/10.1136/annrheumdis-2020-218186
Autor:
Tamás Lajtos, Andrea Chicca, Jürg Gertsch, Lukas Corey, György Haskó, Bin Gao, Pal Pacher, János Pálóczi, Katalin Erdelyi, Csaba Mátyás, Balázs Tamás Németh, Resat Cinar, George Kunos, Daniela Nieri, Zoltán Varga
Publikováno v:
British Journal of Pharmacology. 175:320-334
Background and aims Beta-caryophyllene (BCP) is a plant-derived FDA approved food additive with anti-inflammatory properties. Some of its beneficial effects in vivo reported to involve activation of cannabinoid 2 receptors (CB2) that are predominantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e897f083cd0952631556e1057bd88fc
https://doi.org/10.1111/bph.13722
https://doi.org/10.1111/bph.13722
Autor:
Pal Pacher, Katalin Erdelyi, Csaba Mátyás, Mintong Nan, György Haskó, Balázs Tamás Németh, Partha Mukhopadhyay, Zoltán Varga, Bin Gao, Tamás Lajtos, János Pálóczi
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 310:H1658-H1670
Alcoholic cardiomyopathy in humans develops in response to chronic excessive alcohol consumption; however, good models of alcohol-induced cardiomyopathy in mice are lacking. Herein we describe mouse models of alcoholic cardiomyopathies induced by chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e93113c8d0378194eab8d1f46f1e7ad
https://doi.org/10.1152/ajpheart.00214.2016
https://doi.org/10.1152/ajpheart.00214.2016
Autor:
Almos Klekner, György Vereb, Miklós Petrás, Burt G. Feuerstein, Elza Friedländer, Eva Pintye, János Szöllosi, Tamás Lajtos
Publikováno v:
Neuro-oncology, vol 15, iss 8
Neuro-Oncology, 15, 1027-40
Neuro-Oncology, 15, 8, pp. 1027-40
Neuro-Oncology, 15, 1027-40
Neuro-Oncology, 15, 8, pp. 1027-40
Item does not contain fulltext Introduction Treatment of astrocytoma is frequently hampered by radioresistance of the tumor. In addition to overexpression of ErbB1/EGFR, functional crosstalk between receptor tyrosine kinases and cell adhesion molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bf498c4f80c23bec7f66e745dd02fd
https://escholarship.org/uc/item/1s6818bz
https://escholarship.org/uc/item/1s6818bz
Autor:
Tamás Lajtos, László Simon, Angelika M. Vollmar, Rolf Müller, György Vereb, Karin von Schwarzenberg
Publikováno v:
Molecular oncology. 8(1)
The HER2 oncogene targeting drug trastuzumab shows remarkable efficacy in patients overexpressing HER2. However acquired or primary resistance develops in most of the treated patients why alternative treatment strategies are strongly needed. As endos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a277c38e0700bade303f643c80cfec
https://pubmed.ncbi.nlm.nih.gov/24055142
https://pubmed.ncbi.nlm.nih.gov/24055142
Autor:
Miklós Petrás, Tamás Lajtos, Éva Pintye, Burt G. Feuerstein, János Szöllősi, György Vereb, Károly Tokési, Béla Sulik
Publikováno v:
AIP Conference Proceedings.
In the United States, a dramatically increased incidence and mortality of brain tumors have been observed over the past decades. Of the ∼44 thousand new cases of primary malignant and benign brain tumors diagnosed per year, high grade astrocytomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::033d5086d8fa0e4afd834b1920c479bb
https://doi.org/10.1063/1.3058983
https://doi.org/10.1063/1.3058983
Publikováno v:
Biophysical Journal. 106:523a
Trastuzumab is the most commonly used humanized monoclonal antibody for specific therapy of breast cancer. Even though its clinical introduction was a breakthrough, a large fraction of the treated tumors are or become resistant. It is well known that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fc3e729821159f42610e863269dc24
https://doi.org/10.1016/j.bpj.2013.11.2920
https://doi.org/10.1016/j.bpj.2013.11.2920